Showing 261 - 280 results of 38,786 for search '(( 50 we decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (mean decrease)) ))', query time: 0.82s Refine Results
  1. 261

    Cycloheximide (CHX) treatment decreases production of rRNA transcripts by POLR1 and POLR3. by Martin Selinger (3195987)

    Published 2019
    “…Graph represents relative fold-induction of 5S rRNA levels in comparison to mock-treated cells, with normalisation to cell number. …”
  2. 262

    OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

    Published 2019
    “…After 4 weeks, when the tumor size was approximately 100 mm<sup>3</sup> (T<sub>0</sub>) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”
  3. 263
  4. 264
  5. 265
  6. 266

    Flow diagram of the study. by Yoonjee Cho (15453454)

    Published 2023
    “…A total of 162 patients were included. The SOFA score on POD 5 was significantly higher in the High-decrease group compared with the Low-decrease group (5.2 ± 2.6 vs. 4.1 ± 2.3; mean difference: 1.1, 95% CI: 0.3 to 1.8; P = 0.005). …”
  7. 267

    Baseline characteristics of patients. by Yoonjee Cho (15453454)

    Published 2023
    “…A total of 162 patients were included. The SOFA score on POD 5 was significantly higher in the High-decrease group compared with the Low-decrease group (5.2 ± 2.6 vs. 4.1 ± 2.3; mean difference: 1.1, 95% CI: 0.3 to 1.8; P = 0.005). …”
  8. 268
  9. 269
  10. 270
  11. 271
  12. 272
  13. 273
  14. 274

    Original data. by Yaotian Fan (5917766)

    Published 2025
    Subjects:
  15. 275
  16. 276
  17. 277
  18. 278
  19. 279

    S1 Dataset - by Nelmo Jordão Manjate (16324619)

    Published 2023
    “…For diagnosis by nasal Ag-RDTs, Panbio was MZN 547.00 (USD 8.90), COVIOS was MZN 768.00 (USD 12.50), and LumiraDx was MZN 798.00 (USD 13.00). Medical supplies expenditures represented the main driver of the final cost (>50%), followed by personnel and overhead costs (mean 15% for each). …”
  20. 280

    SGK1 expression is significantly decreased in the prefrontal cortex of PTSD patients. by Pawel Licznerski (82554)

    Published 2015
    “…Data are expressed as a mean fold change ± standard error of the mean (SEM) (<i>n</i> = 6), compared to healthy controls (<i>n</i> = 6). …”